I et forsøg med raske forsøgspersoner mellem 20 og 80 år havde alder ingen signifikant virkning på prasugrels farmakokinetik eller dets hæmning af trombocytaggregeringen.
In a study of healthy subjects between the ages of 20 and 80 years, age had no significant effect on pharmacokinetics of prasugrel or its inhibition of platelet aggregation.